Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low‐intensity induction with venetoclax

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2021-03, Vol.96 (3), p.E65-E68
Hauptverfasser:	Diao, Stacy, Nichols, E Dan, DiNardo, Courtney, Konopleva, Marina, Ning, Jing, Qiao, Wei, Maiti, Abhishek, DiPippo, Adam J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - administration & dosage Bridged Bicyclo Compounds, Heterocyclic - adverse effects Cytarabine - therapeutic use Decitabine - administration & dosage Female Fluid Therapy Hematology Humans Hydroxyurea - therapeutic use Incidence Leukemia, Myeloid, Acute - complications Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Leukemia, Myelomonocytic, Acute - complications Leukemia, Myelomonocytic, Acute - drug therapy Leukemia, Myelomonocytic, Acute - genetics Leukocytosis - drug therapy Leukocytosis - etiology Lysis Male Middle Aged Myeloid leukemia Phosphate-Binding Proteins - therapeutic use Phosphorus - blood Proto-Oncogene Proteins c-bcl-2 - antagonists & inhibitors Retrospective Studies Sulfonamides - administration & dosage Sulfonamides - adverse effects Tumor Lysis Syndrome - etiology Urate Oxidase - therapeutic use Uric Acid - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!